Inhibrx Biosciences stock gains after FDA accepts drug filing
Investing.com Gold reports: Inhibrx Biosciences stock gains after FDA accepts drug filing. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Inhibrx Biosciences stock gains after FDA accepts drug filing. Full body text was unavailable at ingest time, so this brief is based on headline context.